Recent updates on PCOS research
Developments in research on polycystic ovary syndrome have led to new international guidelines for diagnosis and treatment. Below are recent reports appearing in Endocrine Today, including a debate on disease definitions, patient experiences with health care providers and the role of autoimmunity in the disease process.
New international PCOS guideline aims to streamline care
An international consortium of polycystic ovary syndrome professional societies and organizations issued new evidence-based recommendations and practice points to promote consistent, evidence-based care and improve health outcomes for women with PCOS.
Point/Counter: Are expanding disease definitions unnecessarily labeling women with PCOS?
PCOS is an extremely prevalent condition that likely affects 1 in 5 women to some degree. Our job as physicians is to include women in this discussion and explain accurately where they fit in the spectrum of metabolic risk so that together we can devise a personalized management strategy.
Women with PCOS report lack of trust, emotional support in primary care
Women with polycystic ovary syndrome are more likely to trust a specialist vs. a primary care provider to treat their PCOS-related concerns and report dissatisfaction overall with the level of emotional support they receive from their providers, according to new survey results.
Pharmacotherapy effective weight-loss option in PCOS with obesity
The GLP-1 receptor agonist liraglutide, the weight loss drug orlistat and metformin are effective adjuncts to a low-energy diet and increased physical activity for women with polycystic ovary syndrome and overweight or obesity.
Insulin resistance does not influence anti-Müllerian hormone levels in PCOS
Women with polycystic ovary syndrome had similar anti-Müllerian hormone levels regardless of whether they also had insulin resistance.
Autoimmunity may play role in PCOS etiology
Indian women with polycystic ovary syndrome were nearly eight times more likely to test positive for serum antinuclear antibody vs. healthy controls, suggesting that autoimmunity may play a role in the condition.